Håkan Telenius

Finance

Consumer Services

Health Technology

Profile

Dr. Telenius is based in the Vancouver office, and conducts research and analysis of investment opportunities in the health care and life sciences sectors in general.
Dr. Telenius has 10 years of experience in molecular biology and biotechnology in academic and corporate settings; prior to joining MDS Capital, he was a Senior Scientist with Chromos Molecular Systems.
Dr. Telenius trained in Stockholm and Cambridge (Ph.D.) and has an M.B.A.
from the University of British Columbia.

Former positions of Håkan Telenius

Companies	Position	End
Lumira Capital Investment Management, Inc. Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.	Private Equity Analyst	31/03/2006
Chromos Molecular Systems, Inc. Chromos Molecular Systems, Inc. BiotechnologyHealth Technology Chromos is a cellular engineering and therapeutics company creating value through engineering production quality cell lines for the manufacture of biopharmaceuticals, and developing innovative therapies for infectious diseases, cancer and genetic disorders. Chromos is achieving these objectives with its ACE System (Artificial Chromosome Expression) and REM (Rapid Expansion Method) technologies. In the near term, Chromos will focus on continued commercialization of the ACE System for engineering cell lines. To date Chromos has entered into corporate partnerships related to cell line engineering with partners including Pfizer Inc., Centocor, Inc. and Cambridge Antibody Technology	Corporate Officer/Principal	-

See the detail of Håkan Telenius's experience

Training of Håkan Telenius

University of British Columbia

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies